APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Metabolism and Pharmacokinetics (DMPK) Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Growth and Trends Forecast to 2032

Report ID 17412314012 May 2026121 pages

Choose your research edition.

Industry ResearchDrug Metabolism and Pharmacokinetics (DMPK) Service Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug Metabolism and Pharmacokinetics (DMPK) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Metabolism and Pharmacokinetics (DMPK) Service market include NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs and Labcorp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Metabolism and Pharmacokinetics (DMPK) Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Metabolism and Pharmacokinetics (DMPK) Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Metabolism and Pharmacokinetics (DMPK) Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Company

NuChem Sciences Inc

Sygnature Discovery

Paraza Pharma, Inc

Dalriada

Inotiv

Eurofins Discovery

RTI International

Frontage Labs

Labcorp

Jubilant Biosys

Creative Biolabs

Evotec

Charles River

Anthem Bio Sciences

Molecular Diagnostic Services, Inc

Invitrocue

TCG Lifesciences Private Limited

Q 2 Solutions

WuXi AppTec

oncodesign service

Alliance Pharma, Inc

QPS Holdings

NUVISAN

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Type

In Vivo Drug Metabolism and Pharmacokinetics Services

In Vitro Drug Metabolism and Pharmacokinetics Services

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Application

Pharmaceutical Research and Development

Biotechnology

Efficacy Testing

Others

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Metabolism and Pharmacokinetics (DMPK) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Metabolism and Pharmacokinetics (DMPK) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Metabolism and Pharmacokinetics (DMPK) Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021-2026) Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2027-2032) Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2026) Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2026) Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends Table 37. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Drivers Table 38. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Opportunities and Challenges Table 39. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Restraints Table 40. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Company (2021-2026) Table 42. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Key Company Headquarters & Area Served Table 44. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company, Product Type & Application Table 45. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Metabolism and Pharmacokinetics (DMPK) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. NuChem Sciences Inc Company Information Table 49. NuChem Sciences Inc Business Overview Table 50. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 52. NuChem Sciences Inc Recent Development Table 53. Sygnature Discovery Company Information Table 54. Sygnature Discovery Business Overview Table 55. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 57. Sygnature Discovery Recent Development Table 58. Paraza Pharma, Inc Company Information Table 59. Paraza Pharma, Inc Business Overview Table 60. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 62. Paraza Pharma, Inc Recent Development Table 63. Dalriada Company Information Table 64. Dalriada Business Overview Table 65. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 67. Dalriada Recent Development Table 68. Inotiv Company Information Table 69. Inotiv Business Overview Table 70. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 72. Inotiv Recent Development Table 73. Eurofins Discovery Company Information Table 74. Eurofins Discovery Business Overview Table 75. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 77. Eurofins Discovery Recent Development Table 78. RTI International Company Information Table 79. RTI International Business Overview Table 80. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 82. RTI International Recent Development Table 83. Frontage Labs Company Information Table 84. Frontage Labs Business Overview Table 85. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 87. Frontage Labs Recent Development Table 88. Labcorp Company Information Table 89. Labcorp Business Overview Table 90. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 92. Labcorp Recent Development Table 93. Jubilant Biosys Company Information Table 94. Jubilant Biosys Business Overview Table 95. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 97. Jubilant Biosys Recent Development Table 98. Creative Biolabs Company Information Table 99. Creative Biolabs Business Overview Table 100. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 102. Creative Biolabs Recent Development Table 103. Evotec Company Information Table 104. Evotec Business Overview Table 105. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 107. Evotec Recent Development Table 108. Charles River Company Information Table 109. Charles River Business Overview Table 110. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 112. Charles River Recent Development Table 113. Anthem Bio Sciences Company Information Table 114. Anthem Bio Sciences Business Overview Table 115. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 117. Anthem Bio Sciences Recent Development Table 118. Molecular Diagnostic Services, Inc Company Information Table 119. Molecular Diagnostic Services, Inc Business Overview Table 120. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 122. Molecular Diagnostic Services, Inc Recent Development Table 123. Invitrocue Company Information Table 124. Invitrocue Business Overview Table 125. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 127. Invitrocue Recent Development Table 128. TCG Lifesciences Private Limited Company Information Table 129. TCG Lifesciences Private Limited Business Overview Table 130. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 132. TCG Lifesciences Private Limited Recent Development Table 133. Q 2 Solutions Company Information Table 134. Q 2 Solutions Business Overview Table 135. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 137. Q 2 Solutions Recent Development Table 138. WuXi AppTec Company Information Table 139. WuXi AppTec Business Overview Table 140. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 142. WuXi AppTec Recent Development Table 143. oncodesign service Company Information Table 144. oncodesign service Business Overview Table 145. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 147. oncodesign service Recent Development Table 148. Alliance Pharma, Inc Company Information Table 149. Alliance Pharma, Inc Business Overview Table 150. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 152. Alliance Pharma, Inc Recent Development Table 153. QPS Holdings Company Information Table 154. QPS Holdings Business Overview Table 155. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 157. QPS Holdings Recent Development Table 158. NUVISAN Company Information Table 159. NUVISAN Business Overview Table 160. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 162. NUVISAN Recent Development Table 163. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2026) Table 166. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share Forecast by Country (2027-2032) Table 168. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2026) Table 171. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2026) Table 176. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share Forecast by Country (2027-2032) Table 178. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2026) Table 181. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2026) Table 186. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Metabolism and Pharmacokinetics (DMPK) Service Product Image Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021-2032) Figure 7. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. In Vivo Drug Metabolism and Pharmacokinetics Services Image Figure 13. Global In Vivo Drug Metabolism and Pharmacokinetics Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. In Vitro Drug Metabolism and Pharmacokinetics Services Image Figure 15. Global In Vitro Drug Metabolism and Pharmacokinetics Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Type 2025 VS 2032 Figure 18. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2032) Figure 19. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2032) Figure 21. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Type (2021-2032) Figure 23. Pharmaceutical Research and Development Image Figure 24. Global Pharmaceutical Research and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Biotechnology Image Figure 26. Global Biotechnology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Efficacy Testing Image Figure 28. Global Efficacy Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Application 2025 VS 2032 Figure 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2032) Figure 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2032) Figure 36. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Drug Metabolism and Pharmacokinetics (DMPK) Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 43. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 49. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo Drug Metabolism and Pharmacokinetics Services
  • In Vitro Drug Metabolism and Pharmacokinetics Services
Applications
  • Pharmaceutical Research and Development
  • Biotechnology
  • Efficacy Testing
  • Others
Companies covered
  • NuChem Sciences Inc
  • Sygnature Discovery
  • Paraza Pharma, Inc
  • Dalriada
  • Inotiv
  • Eurofins Discovery
  • RTI International
  • Frontage Labs
  • Labcorp
  • Jubilant Biosys
  • Creative Biolabs
  • Evotec
  • Charles River
  • Anthem Bio Sciences
  • Molecular Diagnostic Services, Inc
  • Invitrocue
  • TCG Lifesciences Private Limited
  • Q 2 Solutions
  • WuXi AppTec
  • oncodesign service
  • Alliance Pharma, Inc
  • QPS Holdings
  • NUVISAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  8. 1.5.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (2021-2032)
2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 In Vivo Drug Metabolism and Pharmacokinetics Services
  3. 2.1.2 In Vitro Drug Metabolism and Pharmacokinetics Services
  4. 2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type
  5. 2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Regions
  9. 2.3.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Type (2021-2026)
3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Research and Development
  3. 3.1.2 Biotechnology
  4. 3.1.3 Efficacy Testing
  5. 3.1.4 Others
  6. 3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application
  7. 3.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Regions
  11. 3.3.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
  2. 4.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Drivers
  3. 4.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Opportunities and Challenges
  4. 4.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (2021-2026)
  2. 5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Key Company Headquarters & Area Served
  4. 5.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company, Product Type & Application
  5. 5.5 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Metabolism and Pharmacokinetics (DMPK) Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Metabolism and Pharmacokinetics (DMPK) Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 NuChem Sciences Inc
  2. 6.1.1 NuChem Sciences Inc Company Information
  3. 6.1.2 NuChem Sciences Inc Business Overview
  4. 6.1.3 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  6. 6.1.5 NuChem Sciences Inc Recent Developments
  7. 6.2 Sygnature Discovery
  8. 6.2.1 Sygnature Discovery Company Information
  9. 6.2.2 Sygnature Discovery Business Overview
  10. 6.2.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  12. 6.2.5 Sygnature Discovery Recent Developments
  13. 6.3 Paraza Pharma, Inc
  14. 6.3.1 Paraza Pharma, Inc Company Information
  15. 6.3.2 Paraza Pharma, Inc Business Overview
  16. 6.3.3 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  18. 6.3.5 Paraza Pharma, Inc Recent Developments
  19. 6.4 Dalriada
  20. 6.4.1 Dalriada Company Information
  21. 6.4.2 Dalriada Business Overview
  22. 6.4.3 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  24. 6.4.5 Dalriada Recent Developments
  25. 6.5 Inotiv
  26. 6.5.1 Inotiv Company Information
  27. 6.5.2 Inotiv Business Overview
  28. 6.5.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  30. 6.5.5 Inotiv Recent Developments
  31. 6.6 Eurofins Discovery
  32. 6.6.1 Eurofins Discovery Company Information
  33. 6.6.2 Eurofins Discovery Business Overview
  34. 6.6.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  36. 6.6.5 Eurofins Discovery Recent Developments
  37. 6.7 RTI International
  38. 6.7.1 RTI International Company Information
  39. 6.7.2 RTI International Business Overview
  40. 6.7.3 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  42. 6.7.5 RTI International Recent Developments
  43. 6.8 Frontage Labs
  44. 6.8.1 Frontage Labs Company Information
  45. 6.8.2 Frontage Labs Business Overview
  46. 6.8.3 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  48. 6.8.5 Frontage Labs Recent Developments
  49. 6.9 Labcorp
  50. 6.9.1 Labcorp Company Information
  51. 6.9.2 Labcorp Business Overview
  52. 6.9.3 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  54. 6.9.5 Labcorp Recent Developments
  55. 6.10 Jubilant Biosys
  56. 6.10.1 Jubilant Biosys Company Information
  57. 6.10.2 Jubilant Biosys Business Overview
  58. 6.10.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  60. 6.10.5 Jubilant Biosys Recent Developments
  61. 6.11 Creative Biolabs
  62. 6.11.1 Creative Biolabs Company Information
  63. 6.11.2 Creative Biolabs Business Overview
  64. 6.11.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  66. 6.11.5 Creative Biolabs Recent Developments
  67. 6.12 Evotec
  68. 6.12.1 Evotec Company Information
  69. 6.12.2 Evotec Business Overview
  70. 6.12.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  72. 6.12.5 Evotec Recent Developments
  73. 6.13 Charles River
  74. 6.13.1 Charles River Company Information
  75. 6.13.2 Charles River Business Overview
  76. 6.13.3 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  78. 6.13.5 Charles River Recent Developments
  79. 6.14 Anthem Bio Sciences
  80. 6.14.1 Anthem Bio Sciences Company Information
  81. 6.14.2 Anthem Bio Sciences Business Overview
  82. 6.14.3 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  84. 6.14.5 Anthem Bio Sciences Recent Developments
  85. 6.15 Molecular Diagnostic Services, Inc
  86. 6.15.1 Molecular Diagnostic Services, Inc Company Information
  87. 6.15.2 Molecular Diagnostic Services, Inc Business Overview
  88. 6.15.3 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  90. 6.15.5 Molecular Diagnostic Services, Inc Recent Developments
  91. 6.16 Invitrocue
  92. 6.16.1 Invitrocue Company Information
  93. 6.16.2 Invitrocue Business Overview
  94. 6.16.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  96. 6.16.5 Invitrocue Recent Developments
  97. 6.17 TCG Lifesciences Private Limited
  98. 6.17.1 TCG Lifesciences Private Limited Company Information
  99. 6.17.2 TCG Lifesciences Private Limited Business Overview
  100. 6.17.3 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  102. 6.17.5 TCG Lifesciences Private Limited Recent Developments
  103. 6.18 Q 2 Solutions
  104. 6.18.1 Q 2 Solutions Company Information
  105. 6.18.2 Q 2 Solutions Business Overview
  106. 6.18.3 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  108. 6.18.5 Q 2 Solutions Recent Developments
  109. 6.19 WuXi AppTec
  110. 6.19.1 WuXi AppTec Company Information
  111. 6.19.2 WuXi AppTec Business Overview
  112. 6.19.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  114. 6.19.5 WuXi AppTec Recent Developments
  115. 6.20 oncodesign service
  116. 6.20.1 oncodesign service Company Information
  117. 6.20.2 oncodesign service Business Overview
  118. 6.20.3 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  120. 6.20.5 oncodesign service Recent Developments
  121. 6.21 Alliance Pharma, Inc
  122. 6.21.1 Alliance Pharma, Inc Company Information
  123. 6.21.2 Alliance Pharma, Inc Business Overview
  124. 6.21.3 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  126. 6.21.5 Alliance Pharma, Inc Recent Developments
  127. 6.22 QPS Holdings
  128. 6.22.1 QPS Holdings Company Information
  129. 6.22.2 QPS Holdings Business Overview
  130. 6.22.3 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  132. 6.22.5 QPS Holdings Recent Developments
  133. 6.23 NUVISAN
  134. 6.23.1 NUVISAN Company Information
  135. 6.23.2 NUVISAN Business Overview
  136. 6.23.3 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  138. 6.23.5 NUVISAN Recent Developments
7 North America
  1. 7.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  3. 7.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  3. 10.3 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst